Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Consumer Discretionary | 6.04% |
| 3 | Financials | 5.89% |
| 4 | Industrials | 4.61% |
| 5 | Healthcare | 4.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Alaunos Therapeutics
TCRT
$4.71M
| $670K | ﹤0.01% |
705
+64
| +10% | +$59.6K |
|
4402
Belden
BDC
$5.31B
| $669K | ﹤0.01% |
+9,675
| New | +$711K |
|
4403
CALL
Principal Financial Group
PFG
$24.4B
| $669K | ﹤0.01% |
10,600
+1,400
| +15% | +$85.4K |
|
4404
ProShares UltraPro S&P 500
UPRO
$5.82B
| $669K | ﹤0.01% |
41,814
+26,214
| +168% | +$400K |
|
|
IPHI
4405
CALL
DELISTED
INPHI CORPORATION
IPHI
| $669K | ﹤0.01% |
13,700
-11,700
| -46% | -$546K |
|
4406
CALL
Scotiabank
BNS
$112B
| $668K | ﹤0.01% |
11,400
-4,700
| -29% | -$279K |
|
4407
CALL
Matador Resources
MTDR
$6.64B
| $668K | ﹤0.01% |
28,100
-12,600
| -31% | -$315K |
|
4408
CALL
Valvoline
VVV
$4.36B
| $668K | ﹤0.01% |
27,200
-22,300
| -45% | -$510K |
|
|
ERUS
4409
DELISTED
iShares MSCI Russia ETF
ERUS
| $668K | ﹤0.01% |
20,801
+5,925
| +40% | +$196K |
|
4410
ProShares Large Cap Core Plus
CSM
$537M
| $667K | ﹤0.01% |
22,842
-23,476
| -51% | -$673K |
|
4411
CALL
Winnebago Industries
WGO
$892M
| $667K | ﹤0.01% |
22,800
-4,400
| -16% | -$140K |
|
|
QVCGA
4412
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $667K | ﹤0.01% |
686
-95
| -12% | -$89.3K |
|
4413
CALL
Precigen
PGEN
$2.18B
| $666K | ﹤0.01% |
33,600
-118,658
| -78% | -$2.65M |
|
|
GLOP
4414
DELISTED
GASLOG PARTNERS LP
GLOP
| $666K | ﹤0.01% |
+27,197
| New | +$625K |
|
|
PTLA
4415
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $666K | ﹤0.01% |
17,000
-5,100
| -23% | -$162K |
|
4416
Advanced Energy
AEIS
$13.2B
| $665K | ﹤0.01% |
+9,696
| New | +$599K |
|
4417
CALL
Huazhu Hotels Group
HTHT
$12.9B
| $664K | ﹤0.01% |
42,800
+26,800
| +168% | +$375K |
|
4418
MYR Group
MYRG
$5.21B
| $664K | ﹤0.01% |
16,194
-2,497
| -13% | -$97.2K |
|
|
AYX
4419
DELISTED
Alteryx Inc
AYX
| $664K | ﹤0.01% |
+42,503
| New | +$647K |
|
4420
CALL
ATI
ATI
$31.1B
| $663K | ﹤0.01% |
36,900
-1,100
| -3% | -$20.7K |
|
4421
Fresenius Medical Care
FMS
$12.7B
| $663K | ﹤0.01% |
15,729
+3,909
| +33% | +$162K |
|
4422
CALL
Iron Mountain
IRM
$38.5B
| $663K | ﹤0.01% |
18,600
-1,100
| -6% | -$38.9K |
|
|
TGH
4423
DELISTED
Textainer Group Holdings limited
TGH
| $663K | ﹤0.01% |
+43,327
| New | +$591K |
|
|
TAHO
4424
PUT
DELISTED
Tahoe Resources Inc
TAHO
| $663K | ﹤0.01% |
82,600
+40,800
| +98% | +$352K |
|
|
ORBK
4425
DELISTED
Orbotech Ltd
ORBK
| $663K | ﹤0.01% |
20,557
+14,445
| +236% | +$467K |
|
Similar funds
Ken Griffin's Q1 2017 Portfolio in Review
As of Q1 2017, Ken Griffin held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin's Q1 2017 filing shows 1,446 new, 2,646 increased, 3,048 reduced and 1,267 closed positions. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M. The largest sale was Alphabet (Google) Class A, an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 5.7% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Griffin's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Ken Griffin added most to Microsoft in Q1 2017, an estimated $529M increase.
- Ken Griffin's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Ken Griffin fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Ken Griffin's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Ken Griffin opened 1,446 new positions and closed 1,267 in Q1 2017.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.